Z-2227-2012 Class III Terminated

Recalled by Beckman Coulter Inc. — Brea, CA

FDA device recall Z-2227-2012 was initiated by Beckman Coulter Inc. on Oct 11, 2011 and is designated Class III. Reason for recall: A recall was initiated because Beckman Coulter has identified a negative bias in test results when comparing elevated Total T3 patient samples diluted with Sample Diluent A to samples diluted with… The recall status is terminated (terminated Mar 14, 2013). Affected quantity: 117,385 units total (33,918 units in US).

Recall details

Product Type
Devices
Report Date
Aug 29, 2012
Initiation Date
Oct 11, 2011
Termination Date
Mar 14, 2013
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
117,385 units total (33,918 units in US)

Product description

Access Total T3 Reagent, PN: 33830 The Access Total T3 assay is used for the quantitative determination of triiodothyronine (T3) levels in human serum and plasma in the assessment of thyroid function and diagnosis of thyroid disorders when T3 levels are between 0.1 and 8.0 ng/mL.

Reason for recall

A recall was initiated because Beckman Coulter has identified a negative bias in test results when comparing elevated Total T3 patient samples diluted with Sample Diluent A to samples diluted with Access Total T3 Calibrator S0.

Distribution pattern

Worldwide Distribution - USA (nationwide), Canada, and internationally.

Code information

All Lots

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2227-2012
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2227-2012. Report a data issue: hello@regdatalab.com.